hers and semaglutide Hims & shares fall after FDA says no longer in shortage Hims & Hers Health stock

GLP-1 drugs carry real safety risks that the FDA formalized in updated labeling in 2025, and the long-term effects of taking these medications for longevity purposes in otherwise healthy people remain entirely unknown

This allows your body to begin the adjustment process while you are resting, giving you a buffer period to see how you feel before heading into a busy work week

These individuals were randomly assigned to once-weekly injectable semaglutide at a maximum dose of 2.4mg (Wegovy) or placebo, plus lifestyle intervention

Semaglutide should not be used in subjects who have previously experienced a serious hypersensitivity reaction to semaglutide or any of its components

One provider intended to dose 0.25 milligrams (5 units), but prescribed 25 units instead, leading to a patient receiving five times the intended dose and experiencing severe vomiting